Abstract:Hepatocellular carcinoma (HCC) is a hypervascular tumor and accumulating evidence has indicated that stimulation of angiogenesis by HBV may contribute to HCC malignancy. The small protein of hepatitis B virus surface antigen (HBsAg), SHBs, is the most abundant HBV viral protein and has a close clinical association with HCC, however, whether SHBs contributes to HCC angiogenesis remains unknown. This study reports that forced expression of SHBs in HCC cells promoted xenograft tumor growth and increased the microvessel density (MVD) within the tumors. Consistently, HBsAg was also positively correlated with MVD count in HCC patients' specimens. The conditioned media from the SHBs-transfected HCC cells increased the capillary tube formation and migration of human umbilical vein endothelial cells (HUVECs). Intriguingly, overexpression of SHBs increased VEGFA expression at both mRNA and protein levels. A higher VEGFA expression level was also observed in the xenograft tumors transplanted with SHBs-expressing HCC cells and in HBsAg-positive HCC tumor tissues as compared to their negative controls. As expected, in the culture supernatants, the secretion of VEGFA was also significantly enhanced from HCC cells expressing SHBs, which promoted HUVECs migration and vessel formation. Furthermore, all the three unfolded protein response (UPR) sensors IRE1α, PERK and ATF6 associated with endoplasmic reticulum (ER) stress were found activated in the SHBs-expressing cells and correlated with VEGFA protein expression and secretion. Taken together, these results suggest an important role of SHBs in HCC angiogenesis and may highlight a potential target for preventive and therapeutic intervention of HBV-related HCC and its malignant progression. IMPORTANCE Chronic hepatitis B virus infection is one of the important risk factors for the development and progression of hepatocellular carcinoma (HCC). HCC is characteristic of hypervascularization even at early phases of the disease due to overexpression of angiogenic factors like vascular endothelial growth factor-A (VEGFA). However, a detailed mechanism in the HBV-induced angiogenesis remains to be established. In this study, we demonstrate for the first time that the most abundant HBV viral protein, i.e. small surface antigens (SHBs) can enhance the angiogenic capacity of HCC cells by upregulation of VEGFA expression both in vitro and in vivo . Mechanistically, SHBs induced endoplasmic reticulum (ER) stress which consequently activated unfolded protein response (UPR) signaling to increase VEGFA expression and secretion. This study suggests that SHBs plays an important pro-angiogenic role in HBV-associated HCC and may represent a potential target for anti-angiogenic therapy in the HCC.

Hepatitis B X Antigen Up-Regulates Vascular Endothelial Growth Factor Receptor 3 In Hepatocarcinogenesis

Hepatitis B Virus X Protein Activates Expression of IGF-IR and VEGF in Hepatocellular Carcinoma Cells.

Upregulated Expression of a Unique Gene by Hepatitis B X Antigen Promotes Hepatocellular Growth and Tumorigenesis.

Hepatitis B virus X protein promotes hepatoma cell invasion and metastasis by stabilizing Snail protein

Hbx Elevates Oncoprotein Aeg-1 Expression to Promote Cell Migration by Downregulating Mir-375 and Mir-136 in Malignant Hepatocytes

Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma

Elevated Hmgb1 Expression Induced By Hepatitis B Virus X Protein Promotes Epithelial-Mesenchymal Transition And Angiogenesis Through Stat3/Mir-34a/Nf-Kappa B In Primary Liver Cancer

Hepatitis B Virus X Protein Promotes Human Hepatoma Cell Growth Via Upregulation of Transcription Factor AP2α and Sphingosine Kinase 1

Hepatitis B Virus X Protein Promotes P3 Transcript Expression of the Insulin‐like Growth Factor 2 Gene Via Inducing Hypomethylation of P3 Promoter in Hepatocellular Carcinoma

Hepatitis B Virus X Protein Promotes Hepatoma Cell Proliferation Via Upregulation of Mekk2

Up-regulation of NF kappa B-dependent APG gene by hepatitis B virus-encoded X antigen in hepatocellular carcinoma

Hepatitis B Virus Large Surface Antigen Promotes Tumorigenesis of Human Hepatocellular Carcinoma Cells through Activating Src / PI 3 K / Akt Pathway

HBx acts as an oncogene and promotes the invasion and metastasis of hepatocellular carcinoma both in vivo and vitro

The Effects and Underlying Mechanisms of Hepatitis B Virus X Gene Mutants on the Development of Hepatocellular Carcinoma

Hepatitis B Virus X Protein Modulates P90 Ribosomal S6 Kinase 2 by ERK to Promote Growth of Hepatoma Cells

Hepatitis B Virus X Protein Contributes to Hepatocellular Carcinoma via Upregulation of KIAA1429 Methyltransferase and mRNA m6A Hypermethylation of HSPG2/Perlecan

Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice.

Hepatitis B virus small envelope protein promotes HCC angiogenesis via ER stress signaling to upregulate VEGFA expression

Hepatitis B Virus X Protein Increases Microrna-21 Expression and Accelerates the Development of Hepatoma Via the Phosphatase and Tensin Homolog/Phosphoinositide 3-Kinase/protein Kinase B Signaling Pathway

Hepatitis B Virus X Protein Activates Notch Signaling By Its Effects On Notch1 And Notch4 In Human Hepatocellular Carcinoma

Hepatitis B Virus X Protein (HBx) Suppresses Transcription Factor EB (TFEB) Resulting in Stabilization of Integrin Beta 1 (ITGB1) in Hepatocellular Carcinoma Cells